Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1031250676Recruiting
Randomised trial of propofol, remimazolam and remifentanil (2 arms), sponsored by Nihon University Itabashi Hospital. Primary endpoints: Autonomic circulatory regulation and Cerebral autoregulation. Started Mar 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1031250676.